Heat stable carbetocin is much more expensive than oxytocin. The drug company that makes it has an agreement with WHO to make it available at a reasonable price in poor countries but the devil is in the detail, what will it actually cost ? Which countries will receive it ? For how long ? Will it reduce availability of the cheaper oxytocin ? And what about poor mothers in rich countries ? These are all factors that need to be considered.

More Quotes by Ian Roberts